277 related articles for article (PubMed ID: 34759915)
1. Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2.
Wines BD; Trist HM; Esparon S; Impey RE; Mackay GA; Andrews RK; Soares da Costa TP; Pietersz GA; Baker RI; Hogarth PM
Front Immunol; 2021; 12():666813. PubMed ID: 34759915
[TBL] [Abstract][Full Text] [Related]
2. Mapping the functional topography of Fc gamma with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptor on human K cells.
Sármay G; Jefferis R; Klein E; Benczur M; Gergely J
Eur J Immunol; 1985 Oct; 15(10):1037-42. PubMed ID: 2414110
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
4. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
[TBL] [Abstract][Full Text] [Related]
5. A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.
Rijkers M; Saris A; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Bierings R; Leebeek FWG; Jansen AJG; Vidarsson G; Voorberg J; de Haas M
Haematologica; 2018 Oct; 103(10):1741-1752. PubMed ID: 29858387
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs.
Mimoto F; Kadono S; Katada H; Igawa T; Kamikawa T; Hattori K
Mol Immunol; 2014 Mar; 58(1):132-8. PubMed ID: 24334029
[TBL] [Abstract][Full Text] [Related]
7. Development of a cell-based assay measuring the activation of FcγRIIa for the characterization of therapeutic monoclonal antibodies.
Tada M; Ishii-Watabe A; Suzuki T; Kawasaki N
PLoS One; 2014; 9(4):e95787. PubMed ID: 24752341
[TBL] [Abstract][Full Text] [Related]
8. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
Leon PE; He W; Mullarkey CE; Bailey MJ; Miller MS; Krammer F; Palese P; Tan GS
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5944-E5951. PubMed ID: 27647907
[TBL] [Abstract][Full Text] [Related]
9. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
10. Antibody C region influences TGN1412-like functional activity in vitro.
Ball C; Fox B; Hufton S; Sharp G; Poole S; Stebbings R; Eastwood D; Findlay L; Parren PW; Thorpe R; Bristow A; Thorpe SJ
J Immunol; 2012 Dec; 189(12):5831-40. PubMed ID: 23150712
[TBL] [Abstract][Full Text] [Related]
11. Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancer.
Richman LP; Vonderheide RH
Cancer Immunol Res; 2014 Jan; 2(1):19-26. PubMed ID: 24416732
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.
Greenman J; Hogg N; Nikoletti S; Slade C; Stevenson G; Glennie M
Cancer Immunol Immunother; 1992; 34(6):361-9. PubMed ID: 1532922
[TBL] [Abstract][Full Text] [Related]
13. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
Goroff DK; Finkelman FD
J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
[TBL] [Abstract][Full Text] [Related]
14. Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function.
Chung AW; Crispin M; Pritchard L; Robinson H; Gorny MK; Yu X; Bailey-Kellogg C; Ackerman ME; Scanlan C; Zolla-Pazner S; Alter G
AIDS; 2014 Nov; 28(17):2523-30. PubMed ID: 25160934
[TBL] [Abstract][Full Text] [Related]
15. The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.
Gogesch P; Dudek S; van Zandbergen G; Waibler Z; Anzaghe M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445651
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors.
Goulet DR; Zwolak A; Williams JA; Chiu ML; Atkins WM
Proteins; 2020 May; 88(5):689-697. PubMed ID: 31702857
[TBL] [Abstract][Full Text] [Related]
17. Fcγ Receptor Activation by Human Monoclonal Antibody Aggregates.
Tada M; Aoyama M; Ishii-Watabe A
J Pharm Sci; 2020 Jan; 109(1):576-583. PubMed ID: 31676270
[TBL] [Abstract][Full Text] [Related]
18. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
Arvieux J; Roussel B; Pouzol P; Colomb MG
Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
[TBL] [Abstract][Full Text] [Related]
19. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
20. Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody.
Santostefano MJ; Kirchner J; Vissinga C; Fort M; Lear S; Pan WJ; Prince PJ; Hensley KM; Tran D; Rock D; Vargas HM; Narayanan P; Jawando R; Rees W; Reindel JF; Reynhardt K; Everds N
Toxicol Pathol; 2012 Aug; 40(6):899-917. PubMed ID: 22552394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
